Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

Share Price is delayed by 15 minutes
Get Live Data
49.00    0.00 (0.00%)
Bid:
48.00
Ask:
50.00
Spread: 2.00 (4.167%)
Market Cap: £35.50m
PCIP Live PriceLast checked at - London Stock Exchange

Intraday Pci-pal Share Chart

Trading Update

3 Feb 2026 07:00

RNS Number : 4057R
PCI-PAL PLC
03 February 2026
 

 

3 February 2026

 

PCI-PAL PLC

("PCI Pal", the "Company" or "the Group")

 

Trading Update

 

Strong momentum and record increase in ARR

 

PCI-PAL PLC (AIM: PCIP), the global cloud provider of secure payment solutions for business communications, is pleased to announce a trading update for the six months to 31 December 2025 (the "Period" or "H1").

 

The Group has delivered a further record H1 for new business won, which together with increasingly efficient customer deployments, has contributed to a record real-term increase in ARR for a six month period. At the end of H1, ARR stood at £20.3m, a 21% increase year on year (25% on a constant currency basis), and CARR, the Company's leading indicator of future ARR, reached £24.0m, an increase of 18% year on year (21% on a constant currency basis).

 

Revenue for the Period was £11.3m, a 7% year on year increase, and an increase of 14% on a normalised basis1.

 

Customer retention remains strong with GRR at 95% (2024: 95%), and NRR increased to 105% (2024: 103%). PCI Pal's cloud platform uptime was 100% across the half year, supporting continued customer confidence and retention, whilst illustrating the strength of the Company's global cloud platform.

 

Cash at Period end was £2.6m, reflecting the additional cash investment outlined to investors in September 2025. The Group has no bank debt.

 

Commenting on progress in the Period, James Barham, Chief Executive Officer of PCI Pal, said:

 

"It has been a strong period of trading for the business. We are seeing the highest levels of demand for our core secure payments products, delivering the highest level of new business secured in any first half period of trading, and a highly encouraging sales pipeline as we enter H2.

 

"With continued investment in the Company's integrated partner eco-system, it is particularly pleasing to see the momentum we are building with key strategic partners as we further deepen those relationships. During the Period we have grown both our SMB and enterprise customer base as planned, including further penetration of the US healthcare sector, a key target growth vertical for the Company.

 

"With this progress in H1, we enter the second half with strong momentum and confidence in the Group's ability to continue delivering against its strategic objectives and the Board's expectations for FY26."

 

1. Adjusted for the impact of revenues that were deferred from FY24 and recognised in FY25.

 

For further information, please contact:

 

PCI-PAL PLC

Via Walbrook PR

James Barham - Chief Executive Officer

Ryan Murray - Chief Financial Officer

 

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

+44 (0) 20 7220 0500

Marc Milmo/Fergus Sullivan/Finn Gordon (Corporate Finance)

Sunila De Silva (Corporate Broking)

 

Walbrook PR

+44 (0) 20 7933 8780

Tom Cooper/Nick Rome

+44 (0) 797 122 1972

tom.cooper@walbrookpr.com

 

About PCI Pal:

 

PCI Pal is a leading provider of Software-as-a-Service ("SaaS") solutions that empower companies to take payments from their customers securely, adhere to strict industry governance, and remove their business from the significant risks posed by non-compliance and data loss. Our products secure payments and data in any business communications environment including voice, chat, social, email, and contact centre. We are integrated to, and resold by, some of the worlds' leading business communications vendors, as well as major payment service providers.

 

The entirety of our product-base is available from our global cloud platform hosted in Amazon Web Services ("AWS"), with regional instances across EMEA, North America, and ANZ.

 

For more information visit www.pcipal.com or follow the team on Linkedin: https://www.linkedin.com/company/pci-pal/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVLLFBQLLZBBL
Date   Source Headline
28th Jun 20241:15 pmRNSIssue of Equity & Total Voting Rights
27th Jun 20247:00 amRNSSettlement of UK and US Patent Litigation
5th Jun 20243:02 pmRNSIssue of Equity & TVR
4th Jun 20241:40 pmRNSFurther details following successful COA hearing
22nd May 20247:00 amRNSVictory for PCI Pal in Court of Appeal
17th Apr 20245:45 pmRNSHolding(s) in Company
8th Apr 202410:28 amRNSIssue of Equity & TVR
5th Apr 20247:00 amRNSIssue of Options & Director Share Purchases
4th Apr 202410:24 amRNSIssue of Equity & TVR
28th Mar 20246:15 pmRNSHolding(s) in Company
27th Mar 20247:00 amRNSExercise of Options, Director/PCA Dealings & TVR
26th Mar 202410:57 amRNSPDMR Issue of Options
12th Mar 202412:55 pmRNSResult of Oversubscribed Placing & TVR
12th Mar 20247:00 amRNSProposed Placing to raise up to £3.5m
27th Feb 20247:00 amRNSInterim Results, Board Change & Presentations
20th Feb 20247:00 amRNSNotice of Results, Analyst & Investor Presentation
6th Feb 20247:00 amRNSTrading Update & Notice of Results
26th Jan 202412:50 pmRNSUK Patent Case Update
22nd Jan 20244:59 pmRNSHolding(s) in Company
15th Jan 202412:20 pmRNSIssue of Equity
20th Dec 20237:00 amRNSSuccessful Completion of Form of Order Hearing
19th Dec 20237:00 amRNSUK Court Hearing
12th Dec 20231:40 pmRNSResult of AGM
12th Dec 20237:00 amRNSAGM Statement
24th Nov 202310:45 amRNSAnnual Financial Report & Notice of AGM
13th Nov 20237:00 amRNSNew strategic reseller partnership with Zoom
9th Nov 20237:00 amRNSFinal Results, Analyst Briefing & Investor Pres
6th Nov 20237:00 amRNSNotice of Results Analyst Briefing & Investor Pres
5th Oct 202311:49 amRNSIssue of Equity
4th Oct 20235:13 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSDetail on Patent Case Outcome & Trading Update
25th Sep 20235:29 pmRNSTotal Victory for PCI Pal in UK High Court
4th Sep 20237:00 amRNSHolding(s) in Company
26th Jun 202311:33 amRNSHolding(s) in Company
7th Jun 20237:00 amRNSBreach of confidentiality agreement by Sycurio Ltd
30th May 20237:00 amRNSDirector/PDMR Share Purchase
25th May 202311:08 amRNSDirector/PDMR Share Purchase
24th May 20237:00 amRNSTrading and Patent Case Updates
14th Mar 20237:00 amRNSInterim Results, Analyst Briefing & Investor Pres
13th Mar 20237:49 amRNSSVB Update
28th Feb 20237:00 amRNSNotice of Results, Analyst Call & Investor Pres
2nd Feb 20237:00 amRNSTrading Update & Notice of Results
27th Oct 202212:32 pmRNSResult of AGM
27th Oct 20227:00 amRNSAGM Statement
20th Oct 20227:00 amRNSPDMR Shareholding
7th Oct 20227:00 amRNSDirector/PDMR Issue of Options
6th Oct 20223:13 pmRNSDirector/PDMR share purchase
4th Oct 202210:37 amRNSAnnual Financial Report & Notice of AGM
22nd Sep 20227:00 amRNSPCI Pal launches open banking payments product
6th Sep 20227:00 amRNSFinal Results, Analyst Briefing & Investor Pres

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.